Mounting evidence has revealed that IL-33 levels are elevated within the serum or tissue under inflammation-associated diseased conditions, such as heart failure, atherosclerosis, asthma, sepsis, trauma and pulmonary fibrosis (20, 25, 27). This evidence concerns the gene IL33 and asthma.